Life Sciences WA Investment Series launch – Investor Meets Innovator

The Life Sciences WA Investment Series will connect Western Australian investors with the next generation of innovators from the life sciences industry. Together we will explore the unique life science investment opportunities available in WA and provide guidance as to how to access them.

Join us as we launch the Series, exploring opportunities in the digital health for the WA pharmaceutical and device landscape. The event will feature presentations from Bronwyn Le Grice from ANDHealth, Rob McKenzie, Board Member of the Perron Institute for Neurological and Translational Science and co-managing partner of McKenzie Moncrieff, and a fireside chat with VeinTech and Biotome, moderated by Life Sciences WA Vice-Chair Tracey Wilkinson.

Keep the conversation going with light food and drinks provided after the formalities if you’re attending in person.

There are a limited places available for this event. Please confirm your attendance promptly to secure your place.

About the speakers

Bronwyn Le Grice

Co-Founder, CEO and Managing Director, ANDHealth

Bronwyn has 20 years executive experience in the health technology sector spanning commercialisation, venture capital, capital raising and industry advocacy. Formerly an Investment Director with healthcare specialist venture capital firm BioScience Managers, between 2012 and 2017 she managed over $65M of private and public equity capital raisings and was actively involved in over $30M of portfolio investments, including a substantial investment into WA success story Anita Medical.

In 2017, Bronwyn co-founded ANDHealth, Australia’s only commercialisation organisation dedicated to digital health. The ANDHealth+ pilot program supported 10 companies to go on to raise over $63 million, create 321 jobs and impact more than 239,000 patients in under four years. The success of the program was recognised through the Australian Government’s largest dedicated investment into digital health commercialisation, with $19.75M awarded to ANDHealth in 2021 to scale up ANDHealth+ and expand the organisation’s other activities. Bronwyn is a Non-Executive Director of Lumos Diagnostics Ltd (ASX.LDX) and was appointed as a Member of the Council of the NHMRC for the 2021-2024 triennium, in addition to a number of other international and national advisory roles.

Rob McKenzie

Co-managing partner of McKenzie Moncrieff and Board Member of the Perron Institute for Neurological and Translational Science.

Mr McKenzie is co-managing partner of McKenzie Moncrieff and counsel at Blackwall Legal LLP, practising in corporate, commercial and dispute resolution areas. With over 40 years’ experience, his focus is on corporate governance, structuring and fundraising, business reorganisations and reconstructions.

Mr McKenzie’s experience spans a wide range of industries such as financial services, health, science, technology, education, professional services, mining, retail and agriculture.

Thank you to our partners

The Life Sciences WA Investment Series has received funding through the WA State Government’s X-TEND Grant program, as part of the New Industries Fund (NIF). This funding will bolster LSWA’s current efforts to increase the awareness of the opportunities available to investors in WA’s burgeoning life science sector.

The Series is supported through funding from MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative, on behalf of the Medical Research Future Fund.

As part of the Series, LSWA is collaborating with experienced life science professionals including ANDHealth to deliver a series of workshops, presentations and a provision of a Reference Guide into commercialisation of digital health, pharmaceuticals and medical devices.

For more information about the Series, contact [email protected]